Real-world effectiveness and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes and renal impairment: a subgroup analysis of the ATOS study

被引：0
|
作者：
Tirosh, A. [1 ,2 ]
Khan, N. [3 ]
Vargas-Uricoechea, H.
Mabunay, M. A. N. [4 ]
Coudert, M. [5 ]
Pilorget, V. [5 ]
Galstyan, G. [6 ]
机构：
[1] Chaim Sheba Med Ctr, Div Endocrinol Diabet & Metab, Tel Hashomer, Israel
[2] Tel Aviv Univ, Tel Hashomer, Israel
[3] Imperial Coll London, Diabet Ctr, Al Ain, U Arab Emirates
[4] Univ Cauca, Div Endocrinol & Metab, Dept Internal Med, Popayan Cauca, Colombia
[5] Sanofi, Singapore, Singapore
[6] Hlth Care Minist Russian Federat, Endocrinol Res Ctr, Moscow, Russia
来源：
DIABETOLOGIA | 2021年 / 64卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
506
引用
收藏
页码：264 / 265
页数：2
相关论文
共 50 条
  • [21] Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naive patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY)
    Fadini, Gian Paolo
    Buzzetti, Raffaella
    Nicolucci, Antonio
    Larosa, Monica
    Rossi, Maria Chiara
    Cucinotta, Domenico
    ACTA DIABETOLOGICA, 2022, 59 (10) : 1317 - 1330
  • [22] EASE OF USE OF THE NEW INSULIN GLARGINE 300 U/ML PEN INJECTOR IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES
    Pohlmeier, H.
    Klonoff, D.
    Berard, L.
    Brulle-Wohlhueter, C.
    Wu, J.
    Dahmen, R.
    Nowotny, I.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A18 - A19
  • [23] Real-World Use of Insulin Glargine U100 and U300 in Insulin-Naive Patients with Type 2 Diabetes Mellitus: DosInGlar Study
    Duque, Natalia
    Artime, Esther
    Romera, Irene
    Lebrec, Jeremie
    Diaz, Silvia
    Rubio, Miriam
    Sicras-Mainar, Antoni
    Carretero-Anibarro, Enrique
    Mundet, Xavier
    Gorgojo-Martinez, Juan J.
    Reviriego, Jesus
    ADVANCES IN THERAPY, 2021, 38 (07) : 3857 - 3871
  • [24] Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naive people with type 2 diabetes: The EDITION AP randomized controlled trial
    Ji, Linong
    Kang, Eun Seok
    Dong, XiaoLin
    Li, Ling
    Yuan, GuoYue
    Shang, Shuhua
    Niemoeller, Elisabeth
    DIABETES OBESITY & METABOLISM, 2020, 22 (04): : 612 - 621
  • [25] Ease of Use of the New Insulin Glargine 300 U/mL SoloSTAR Pen Injector in Insulin-Naive People with Type 2 Diabetes
    Pohlmeier, Harald
    Klonoff, David C.
    Berard, Lori
    Brulle-Wohlhueter, Claire
    Wu, Junlong
    Dahmen, Raphael
    Nowotny, Irene
    DIABETES, 2015, 64 : A269 - A270
  • [26] The effectiveness of insulin glargine 300 U/mL among type 2 diabetes patients: Analysis of a real-world data in Israel
    Cohen, Cheli Melzer
    Banon, Tamar
    Shalev, Varda
    Chodick, Gabriel
    ENDOCRINOLOGY DIABETES & METABOLISM, 2020, 3 (03)
  • [27] Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Who Fast During Ramadan in The Gulf Region: A Subgroup Analysis of the Real-World ORION Study
    Rayaz A. Malik
    Tarik Elhadd
    Abdulnabi Alattar
    Abdulrahman Al Shaikh
    Muneera Al Randi
    Ravi Arora
    Saud Al-Sifri
    Yasser Akil
    Amr Magdy
    Mubarak Naqvi
    Mohamed Hassanein
    Diabetes Therapy, 2022, 13 : 569 - 581
  • [28] Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Who Fast During Ramadan in The Gulf Region: A Subgroup Analysis of the Real-World ORION Study
    Malik, Rayaz A.
    Elhadd, Tarik
    Alattar, Abdulnabi
    Al Shaikh, Abdulrahman
    Al Randi, Muneera
    Arora, Ravi
    Al-Sifri, Saud
    Akil, Yasser
    Magdy, Amr
    Naqvi, Mubarak
    Hassanein, Mohamed
    DIABETES THERAPY, 2022, 13 (03) : 569 - 581
  • [29] New insulin glargine 300 U/ml: glycaemic control and hypoglycaemia in insulin-naive people with type 2 diabetes mellitus (EDITION 3)
    Bolli, G. B.
    Riddle, M. C.
    Bergenstal, R. M.
    Ziemen, M.
    Sestakauskas, K.
    Goyeau, H.
    Home, P. D.
    DIABETOLOGIA, 2014, 57 : S387 - S388
  • [30] Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naive type 2 diabetes: Design and population
    Bonadonna, R. C.
    Giaccari, A.
    Buzzetti, R.
    Aimaretti, G.
    Cucinotta, D.
    Avogaro, A.
    Perseghin, G.
    Larosa, M.
    Bolli, G. B.
    Fanelli, C. G.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2019, 29 (05) : 496 - 503
12345